Drug firm Indoco Remedies on Wednesday reported a consolidated net profit of Rs 7.81 crore for the quarter ended September 30.
The company had posted a net loss of Rs 7.45 crore for the corresponding period of the previous fiscal, Indoco Remedies said in a filing to BSE.
Consolidated revenue from operations of the company stood at Rs 286.21 crore for the quarter under consideration. It was Rs 236.26 crore for the same period year ago.
"During the second quarter, the company's India business saw double digit growth at 17.2 per cent... Sequentially, India business has grown by 15.3 per cent, which indicates good momentum," Indoco Remedies MD Aditi Panandikar said.
On the international business front, with the regulatory challenges easing out, the business in Europe will now take off from here onwards, she added.
Shares of Indoco Remedies were trading at Rs 168 per scrip on BSE, up 9.09 per cent from their previous close.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app